Amphenol Corporation (NYSE:APH) reported a strong finish to 2024, exceeding earnings expectations with an adjusted EPS of $0.55 against a forecast of $0.50. The company also surpassed revenue ...

Abbott Laboratories ABT reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.34, in line with the Zacks ...

It isn’t a bad idea to follow billionaires’ investment strategies. While one must not blindly do what they do, keeping an eye ...

Global Payments has seen quite an underwhelming performance in the last year and YTD. Click here to find out what leads me to ...

The company’s projected adjusted diluted EPS for 2025 is between $5.05 and $5.25, marking double-digit growth at the midpoint. Abbott’s first-quarter 2025 adjusted EPS is expected to be between $1.05 ...

The business has successfully expanded its share in a highly fragmented market from 4% in 2007 to 11% in 2024 in the US through a combination of its “cluster” strategy and bolt-on acquisitions.

Investors faced a unique dynamic in 2024, with a range of catalysts dominating the mind share of most investors. From surging ...

Procter & Gamble is trading near the top of the Dow Wednesday after the consumer staples giant beat expectations for its ...

GE Vernova missed analyst expectations on fourth-quarter EPS and revenue, but it maintained its guidance for the coming year.

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

FB Financial Corporation has shown strong earnings growth, with a 13% increase in EPS and a 20% rise in adjusted pre-tax ...